Doc's note: If you turn on your TV, it won't take long to see a political ad begging you to donate to a campaign for the upcoming midterm elections. And while you're probably already tired of seeing these ads and the signs dotting your neighbors' yards, you might not know that the cycle we're in today can be a boon for your portfolio.

As Brett Eversole explains, the next 12 months tend to be the best for returns...

This bull market feels unstoppable...

Over the past few years, we've seen stocks weather storm after storm – everything from geopolitical tensions and energy shocks to tariffs and wars. But as the hits continue, stocks keep marching higher.

The market's resilience has been especially surprising over the past year.

We're finishing a 12-month period that's typically bad for U.S. stocks. But you'd never know it. Prices have soared double digits over that stretch.

Not only that, but history shows the next 12 months tend to be the best for returns. The reason has to do with an important political cycle... And it tells us that the stock boom will likely continue.

Let me explain...

The Presidential Election Cycle Is About to Turn in Our Favor

The person sitting in the Oval Office matters less to the stock market than you probably think.

Sure, presidents can set policy goals and push legislation. But those are slow changes. And it takes even longer for their effects to trickle into the real economy.

What's more important than who is in office is where we are in their four-year term. This is known as the presidential election cycle.

It might seem odd at first... But stock returns have formed a historical pattern based on the specific year of a president's term.

The first year tends to be good. The second year is terrible. The third year is great. And the fourth year is good again. The differences are even more pronounced if we use the government's fiscal year, ending on September 30, instead of a typical calendar year.

Here are the returns of each year in the election cycle since 1928, using that method...

This is one of those ideas that seems too simple to be true. Yet, for nearly a century, the presidential cycle has been a powerful indicator of stock performance.

And it makes sense if you think about it...

In Year 1, the election has just ended. The market has certainty about who's in charge, so prices tend to rise.

Year 2 brings uncertainty back with the midterm elections. Historically, that's the toughest part of the cycle.

Then, Year 3 comes along. The president starts gearing up for the next election... which means pushing policies that focus on the economy. This change in posture leads to the biggest gains for investors.

In Year 4, the market enjoys the same pro-economy stance, but election uncertainty weighs on returns. The result is another year that's good, but not great.

We're now entering the end of Year 2. That's the only year of the election cycle that typically sees market losses. And yet, stocks have risen about 15% since the end of last September – the same performance as term Year 3.

That's another feather in the cap of this bull market. It seems like no matter what comes around, stock prices keep marching higher.

The good times won't last forever, of course. Every great bull market ends eventually. But history shows we shouldn't expect this one to end soon.

Next week, we'll begin the best year for stocks based on the election-cycle indicator. We've typically seen gains of around 15% in Year 3.

With that historical backdrop on our side, we want to stay bullish right now.

Good investing,

Brett Eversole

Editor's note: Elections aren't the only thing entering a new cycle. According to Brett, we're entering Phase 2 of the AI boom. And Brett believes the market could reprice the entire AI trade. That could lead to some huge winners and losers.

Click here for all the details. 

Recent Articles

View Full Archives
Subscribe to Health & Wealth Bulletin for FREE
Get the Health & Wealth Bulletin delivered straight to your inbox.
About Health & Wealth Bulletin

Here at Health & Wealth Bulletin, our manifesto is to provide a guide for living well – at a good price and on your own terms.

We've told folks the secret to life-changing income in retirement, the exit plan that every investor needs, and the key to beating the market. And our team has been on the leading edge of reporting new discoveries like immunotherapy, the dangers of BPA, the truth about cholesterol, and more.

You see, huge corporate interests and corrupt government institutions would rather people didn't know about many of these concepts... The more ignorant the people are, the better for the government and corporate interests. This keeps folks dependent... and the "nanny state" alive. That's why we spend our days uncovering the truth and sharing it with readers.

Health & Wealth Bulletin is your free guidebook to intriguing health and wealth ideas. It's all about living the best life possible.

About the Editor
Dr. David "Doc" Eifrig
Dr. David "Doc" Eifrig
Editor

Dr. David "Doc" Eifrig has one of the most remarkable resumes of anyone we know in the finance industry. After receiving his Bachelor of Arts degree from Carleton College in Minnesota, he went on to earn a Master of Business Administration degree

from Northwestern University's Kellogg School of Management. There, he graduated on the Dean's List with a double major in finance and international business.

Doc then went to work as an elite derivatives trader at the Goldman Sachs investment bank. He spent a decade on Wall Street with several major institutions, including Chase Manhattan Bank and Yamaichi Securities (then known as the "Goldman Sachs of Japan").

That's when Doc's career took an unconventional turn. Sick of the greed and hypocrisy on Wall Street, he quit his Senior Vice President position to become a doctor. He graduated from Columbia University's postbaccalaureate premedical program and eventually earned his Medical Doctor degree with clinical honors from the University of North Carolina at Chapel Hill. While in medical school, he was elected president of his class and admitted to the Order of the Golden Fleece – the highest honor awarded at the university.

Doc also completed a research fellowship in molecular genetics at Duke University and became a board-eligible eye surgeon. Along the way, he has been published in scientific journals and helped start a small biotechnology company, Mirus Bio, which was sold to Roche for $125 million in 2008.

However, frustrated by Big Medicine's many conflicts, Doc began to look for ways to talk directly with individuals. He wanted to use his background to show them how to take control of their health and wealth. In 2008, Doc joined Stansberry Research and launched his publication, Retirement Millionaire. He has gone on to launch Retirement Trader, which uses options to help people construct safe, reliable income streams. Doc's Income Intelligence seeks out income-producing investments to maximize returns. Prosperity Investor helps investors unlock massive potential gains in health care investing. Every Monday through Friday, Doc shares his views on the latest in the financial and health industries – and tips on how to improve your own life – in Health & Wealth Bulletin.

Doc has also authored five books with four-star ratings (or better) on Amazon. In his spare time, he has run three marathons and several triathlons. He owns and produces his own wine (Eifrig Cellars) in northern Sonoma County, California. Doc is also the CEO of MarketWise, Stansberry Research's parent company.

Back to Top